Rheumatoid arthritis and post-COVID-19 syndrome
https://doi.org/10.47360/1995-4484-2022-276-279
Abstract
In the third year of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2, COVID-19) pandemic doctors are encountering a new pathology – post-COVID-19 syndrome (PCS, long covid). Musculoskeletal manifestations are among the most common and may present as myalgia, arthralgia, or arthritis. Currently, there is no generally accepted definition of the disease, its duration, classification, or diagnostic criteria, and no single view on the “content” of musculoskeletal manifestations of PCS. We have enough descriptions of the debut of rheumatoid arthritis (RA) after SARS-CoV-2. That is a question: it is a coincidence, or COVID-19 may be a trigger factor of RA? We thought that SARS-CoV-2 infection may be a trigger factor for new rheumatic musculoskeletal diseases, including rheumatoid arthritis or COVID-19 can unmask previously undetected RA. The occurrence of arthritis may be a sign of PCS with transient character. So arthritis in the post covid period may induce problems in differential diagnosis of rheumatic diseases.
About the Authors
Ch. T. Baimukhamedov
Shymkent Medical Center for Joint Diseases;
South Kazakhstan Medical Academy
Kazakhstan
Kazakhstan
160011, Shymkent, Sasbukaeva str., 32A;
160001, Shymkent, Al-Farabi square, 1
A. K. Botabekova
Shymkent Medical Center for Joint Diseases;
South Kazakhstan Medical Academy
Kazakhstan
Kazakhstan
160011, Shymkent, Sasbukaeva str., 32A;
160001, Shymkent, Al-Farabi square, 1
G. N. Dossybayeva
South Kazakhstan Medical Academy
Kazakhstan
Kazakhstan
160001, Shymkent, Al-Farabi square, 1
Sh. A. Makhmudov
Shymkent Medical Center for Joint Diseases
Kazakhstan
Kazakhstan
160011, Shymkent, Sasbukaeva str., 32A
References
1. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi: 10.1038/s41598-021-95565-8
2. Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. PostCOVID-19 syndrome: The persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med (Lausanne). 2021;8:653516. doi: 10.3389/fmed.2021.653516
3. Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID19: A systematic review. JAMA Netw Open. 2021;4(5):e2111417. doi: 10.1001/jamanetworkopen.2021.11417
4. Cabrera Martimbianco AL, Pacheco RL, Bagattini ÂM, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J Clin Pract. 2021;75(10):e14357. doi: 10.1111/ijcp.14357
5. Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194-202. doi: 10.1038/s41590-021-01104-y
6. Hayes LD, Ingram J, Sculthorpe NF. More than 100 persistent symptoms of SARS-CoV-2 (long COVID): A scoping review. Front Med (Lausanne). 2021;8:750378. doi: 10.3389/fmed.2021.750378
7. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102-e107. doi: 10.1016/S1473-3099(21)00703-9
8. Nasonov EL, Lila AM, Mazurov VI, Belov BS, Karateev AE, Dubinina TV, et al. Coronavirus disease 2019 (COVID-19) and immune-mediated rheumatic diseases. Recommendations of the Association of Rheumatologists of Russia. Nauchno-Prakticheskaya Revmatologia = Rheumato - logy Science and Practice. 2021;59(3):239-254 (In Russ.). doi: 10.47360/1995-4484-2021-239-254
9. Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of COVID-19: Summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136
10. Sapkota HR, Nune A. Long COVID from rheumatology perspective – A narrative review. Clin Rheumatol. 2022;41(2):337-348. doi: 10.1007/s10067-021-06001-1
11. Weng LM, Su X, Wang XQ. Pain symptoms in patients with coronavirus disease (COVID-19): A literature review. J Pain Res. 2021;14:147-159. doi: 10.2147/JPR.S269206
12. Cipollaro L, Giordano L, Padulo J, Oliva F, Maffulli N. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. J Orthop Surg Res. 2020;15(1):178. doi: 10.1186/s13018-020-01702-w
13. Tang KT, Hsu BC, Chen DY. Autoimmune and rheumatic manifestations associated with COVID-19 in adults: An updated systematic review. Front Immunol. 2021;12:645013. doi: 10.3389/fimmu.2021.645013
14. Karateev AE, Amirdzhanova VN, Nasonov EL, Lila AM, Alekseeva LI, Pogozheva EYu, et al. “Post-COVID syndrome”: The focus is on musculoskeletal pain. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2021;59(3):255-262 (In Russ.). doi: 10.47360/1995-4484-2021-255-262
15. Joob B, Wiwanitkit V. Arthralgia as an initial presentation of COVID-19: observation. Rheumatol Int. 2020;40(5):823. doi: 10.1007/s00296-020-04561-0
16. Kuschner Z, Ortega A, Mukherji P. A case of SARS-CoV-2- associated arthritis with detection of viral RNA in synovial fluid. J Am Coll Emerg Physicians Open. 2021;2(4):e12452. doi: 10.1002/emp2.12452
17. Ono K, Kishimoto M, Shimasaki T, Uchida H, Kurai D, Deshpande GA, et al. Reactive arthritis after COVID-19 infection. RMD Open. 2020;6(2):e001350. doi: 10.1136/rmdopen-2020-001350
18. Yokogawa N, Minematsu N, Katano H, Suzuki T. Case of acute arthritis following SARS-CoV-2 infection. Ann Rheum Dis. 2020 Jun 26:annrheumdis-2020-218281. doi: 10.1136/annrheumdis2020-218281
19. Saricaoglu EM, Hasanoglu I, Guner R. The first reactive arthritis case associated with COVID-19. J Med Virol. 2021;93(1):192-193. doi: 10.1002/jmv.26296
20. Parisi S, Borrelli R, Bianchi S, Fusaro E. Viral arthritis and COVID-19. Lancet Rheumatol. 2020;2(11):e655-e657. doi: 10.1016/S2665-9913(20)30348-9
21. Gasparotto M, Framba V, Piovella C, Doria A, Iaccarino L. Post-COVID-19 arthritis: A case report and literature review. Clin Rheumatol. 2021;40(8):3357-3362. doi: 10.1007/s10067-020-05550-1
22. Liew IY, Mak TM, Cui L, Vasoo S, Lim XR. A case of reactive arthritis secondary to coronavirus disease 2019 infection. J Clin Rheumatol. 2020;26(6):233. doi: 10.1097/RHU.0000000000001560
23. Schenker HM, Hagen M, Simon D, Schett G, Manger B. Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection. Rheumatology (Oxford). 2021;60(1):479-480. doi: 10.1093/rheumatology/keaa689
24. Jali I. Reactive arthritis after COVID-19 infection. Cureus. 2020;12(11):e11761. doi: 10.7759/cureus.11761
25. Danssaert Z, Raum G, Hemtasilpa S. Reactive arthritis in a 37-yearold female with SARS-CoV2 infection. Cureus. 2020;12(8):e9698. doi: 10.7759/cureus.9698
26. Bekaryssova D, Yessirkepov M, Zimba O, Gasparyan AY, Ahmed S. Reactive arthritis before and after the onset of the COVID-19 pandemic. Clin Rheumatol. 2022;41(6):1641-1652. doi: 10.1007/s10067-022-06120-3
27. Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G. New onset of autoimmune diseases following COVID-19 diagnosis. Cells. 2021;10(12):3592. doi: 10.3390/cells10123592
28. Joo YB, Lim YH, Kim KJ, Park KS, Park YJ. Respiratory viral infections and the risk of rheumatoid arthritis. Arthritis Res Ther. 2019;21(1):199. doi: 10.1186/s13075-019-1977-9
29. Kudaeva FM, Speechley MR, Pope JE. A systematic review of viral exposures as a risk for rheumatoid arthritis. Semin Arthritis Rheum. 2019;48(4):587-596. doi: 10.1016/j.semarthrit.2018.03.011
30. Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R. COVID-19 infection and rheumatoid arthritis: Faraway, so close! Autoimmun Rev. 2020;19(5):102523. doi: 10.1016/j.autrev.2020.102523
31. Derksen VFAM, Kissel T, Lamers-Karnebeek FBG, van der Bijl AE, Venhuizen AC, Huizinga TWJ, et al. Onset of rheumatoid arthritis after COVID-19: coincidence or connected? Ann Rheum Dis. 2021 Mar 1:annrheumdis-2021-219859. doi: 10.1136/annrheumdis-2021-219859
32. Baimukhamedov C, Barskova T, Matucci-Cerinic M. Arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021;3(5):e324-e325. doi: 10.1016/S2665-9913(21)00067-9
33. Talarico R, Stagnaro C, Ferro F, Carli L, Mosca M. Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection. Lancet Rheumatol. 2020;2(9):e518-e519. doi: 10.1016/S2665-9913(20)30216-2
34. Zacharias H, Dubey S, Koduri G, D’Cruz D. Rheumatological complications of COVID-19. Autoimmun Rev. 2021;20(9):102883. doi: 10.1016/j.autrev.2021.102883
35. Perrot L, Hemon M, Busnel JM, Muis-Pistor O, Picard C, Zandotti C, et al. First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021;3(1):e6-e8. doi: 10.1016/S2665-9913(20)30396-9
36. Ben-Chetrit E, Ben-Chetrit E. Palindromic rheumatism following COVID-19 infection evolved to rheumatoid arthritis after COVID-19 reinfection. Clin Exp Rheumatol. 2021;39(6):1410-1412.
37. Alshablan A, Jabbad R, Tayeb S, Albeshri T, Yelamanchili SR, Rabie N, et al. Diagnosis of adult onset Still’s disease in a patient who has recovered from Coronavirus-19. Clin Med Insights Case Rep. 2021;14:1179547621996306. doi: 10.1177/1179547621996306
38. Bamidis AD, Koehler P, di Cristanziano V, Rasche K, Demirel B, Bacher P, et al. First manifestation of adult-onset Still’s disease after COVID-19. Lancet Rheumatol. 2021;3(5):e319-e321. doi: 10.1016/S2665-9913(21)00072-2
39. Magliulo D, Narayan S, Ue F, Boulougoura A, Badlissi F. Adult-onset Still’s disease after mRNA COVID-19 vaccine. Lancet Rheumatol. 2021;3(10):e680-e682. doi: 10.1016/S2665-9913(21)00219-8
40. Terracina KA, Tan FK. Flare of rheumatoid arthritis after COVID-19 vaccination. Lancet Rheumatol. 2021;3(7):e469-e470. doi: 10.1016/S2665-9913(21)00108-9
41. Baimukhamedov C, Makhmudov S, Botabekova A. Seropositive rheumatoid arthritis after vaccination against SARS-CoV-2 infection. Int J Rheum Dis. 2021;24(11):1440-1441. doi: 10.1111/1756-185X.14220
42. Lingel H, Meltendorf S, Billing U, Thurm C, Vogel K, Majer C, et al. Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals. J Autoimmun. 2021;122:102682. doi: 10.1016/j.jaut.2021.102682
43. Nasonov EL. Coronavirus disease 2019 (COVID-19) and autoimmunity. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2021;59(1): 5-30 (In Russ.). doi: 10.47360/1995-4484-2021-5-30
44. Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021;20(4):102792. doi: 10.1016/ j.autrev.2021.102792
45. Larionova R, Byvaltsev K, Kravtsova О, Takha E, Petrov S, Kazarian G, et al. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases. J Transl Autoimmun. 2022;5:100154. doi: 10.1016/j.jtauto.2022.100154
46. Mettler C, Jonville-Bera AP, Grandvuillemin A, Treluyer JM, Terrier B, Chouchana L. Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: A global pharmacovigilance study. Rheumatology (Oxford). 2022;61(2):865-867. doi: 10.1093/rheumatology/keab756
47. Ottaviani S, Juge PA, Forien M, Ebstein E, Palazzo E, Dieudé P. Polymyalgia rheumatica following COVID-19 vaccination: A case-series of ten patients. Joint Bone Spine. 2022;89(2):105334. doi: 10.1016/j.jbspin.2021.105334
48. Manzo C, Natale M, Castagna A. Polymyalgia rheumatica as uncommon adverse event following immunization with COVID-19 vaccine: A case report and review of literature. Aging Med (Milton). 2021;4(3):234-238. doi: 10.1002/agm2.12171
49. Osada A, Sakuragi C, Toya C, Mitsuo A. New-onset polymyalgia rheumatica following the administration of the Pfizer-BioNTech COVID-19 vaccine. Intern Med. 2022;61(5):749-753. doi: 10.2169/internalmedicine.8651-21
50. Izuka S, Komai T, Natsumoto B, Shoda H, Fujio K. Self-limited polymyalgia rheumatica-like syndrome following mRNA-1273 SARS-CoV-2 vaccination. Intern Med. 2022;61(6):903-906. doi: 10.2169/internalmedicine.8829-21
51. Ursini F, Ruscitti P, Raimondo V, De Angelis R, Cacciapaglia F, Pigatto E, et al. Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: A report of 66 cases. Ann Rheum Dis. 2022;81(3):440-441. doi: 10.1136/annrheumdis-2021-221587
52. Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, et al.; COVID-19 Global Rheumatology Alliance. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871
53. Nasonov EL, Belov BS, Lila AM, Aronova ES, Gridneva GI, Kudryavtseva AV, et al. Course and outcomes of COVID-19 in patients with immunoinflammatory rheumatic diseases: Preliminary data from the NIIR/ APP-COVID-19 registry and literature review. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2021;59(6): 666-675 (In Russ.). doi: 10.47360/1995-4484-2021-666-675
54. Baimukhamedov C. Elderly-onset rheumatoid arthritis: An outlook from a practicing rheumatologist. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2020;58(4):447-450 (In Russ.). doi: 10.47360/1995-4484-2020-447-450
Review
For citations:
Baimukhamedov Ch.T., Botabekova A.K., Dossybayeva G.N., Makhmudov Sh.A. Rheumatoid arthritis and post-COVID-19 syndrome. Rheumatology Science and Practice. 2022;60(3):276-279. (In Russ.) https://doi.org/10.47360/1995-4484-2022-276-279
Views:
1509
Email this article 